Glucose Health, Inc.

Glucose Health, Inc. manufactures dietary supplements designed to help maintain healthy blood sugar, triglycerides, cholesterol, and digestive health. The company focuses on the consumer market segment of individuals concerned about pre-diabetes and/or Type-2 diabetes. Its principal product is Glucose Health®, which the company acquired in October 2014. Glucose Health, Inc. is in the early stages of manufacturing, marketing, and distributing this product. For the period ending December 31, 2016, the company generated a gross profit before operating expenses, a loss from operations, and a net loss per share. The company was incorporated under the laws of the State of Nevada on March 27, 2007, as Bio-Solutions Corp. On June 30, 2010, the board of directors approved an increase in authorized common stock from 75,000,000 to 90,000,000 shares and a 1.20 for 1 stock split. On October 17, 2012, an amendment was filed with the Nevada Secretary of State, increasing authorized capital from 90,000,000 shares of common stock to 200,000,000 shares of common stock, with a par value of $0.001. On January 10, 2014, the board of directors voted to reverse split the common stock on the basis of one share for each 10 shares outstanding, while maintaining the authorized capital structure at 200,000,000 shares.